Epithelial Stem-cell Transplantation for Severe Ocular-surface Disease
Overview
Authors
Affiliations
Li Z, Yang K, Zhou Y, Wu T, Zhang H, Yang Q Front Med (Lausanne). 2022; 9:986194.
PMID: 36457564 PMC: 9705574. DOI: 10.3389/fmed.2022.986194.
New, potent, small molecule agonists of tyrosine kinase receptors attenuate dry eye disease.
Yu Z, Joy S, Mi T, Yazdanpanah G, Burgess K, de Paiva C Front Med (Lausanne). 2022; 9:937142.
PMID: 36091713 PMC: 9453230. DOI: 10.3389/fmed.2022.937142.
Jurkunas U, Johns L, Armant M Am J Ophthalmol. 2022; 239:244-268.
PMID: 35314191 PMC: 9638843. DOI: 10.1016/j.ajo.2022.03.015.
Kayama M, Kurokawa M, Ueno H, Suzuki N Clin Ophthalmol. 2009; 1(4):373-82.
PMID: 19668514 PMC: 2704521.
Lekhanont K, Choubtum L, Chuck R, Sa-Ngiampornpanit T, Chuckpaiwong V, Vongthongsri A Mol Vis. 2009; 15:1294-302.
PMID: 19578552 PMC: 2704912.